Basic Information
Kinto, an evidence-based, GenAI-supported dementia caregiver support intervention developed in collaboration with the Alzheimer's Association, is redefining the future of dementia care. Backed by over $6 million in federal and state research funding, Kinto has developed a highly scalable artificial intelligence behavioral health intervention that improves the well-being of caregivers and their loved ones while reducing costs. Kinto has successfully completed three clinical trials, including a single-arm feasibility study conducted in partnership with Mass General Brigham and a 300-person randomized controlled efficacy trial in collaboration with the Alzheimer’s Association. Kinto provides an effective and scalable solution for caregiver support and education, addressing a critical yet often missing component in dementia care management.
RSV Opco 5, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2016
programcoordinator@kinto.care

